The skeletal system is the third most common site for cancer metastases, surpassed only by
the lungs and liver. Many tumors, especially those of the breast, prostate, lungs, and …

Statins are known for their beneficial effects on cardiovascular diseases. Besides the lipid-
lowering properties, statins exert their anabolic effects on the bone by differentiating …

Chemokines serve important roles in the development of cancer. C-X3-C motif chemokine
ligand 1 (CX3CL1) has been demonstrated to promote metastases in different types of …

Bone metastasis is the major deleterious event in prostate cancer (PCa). TMPRSS2-ERG
fusion is one of the most common chromosomic rearrangements in PCa. However, its …

The development of functional nanoplatforms to improve the chemotherapy outcome and
inhibit distal cancer cell metastasis remains an extreme challenge in cancer management. In …

In this work we have demonstrated the green synthesis of stable and mono-dispersed Ag
NPs using chitosan/Agar hydrogel having reducing/stabilizing ability avoiding any toxic …

Bone is a preferred metastatic site of prostate cancer (PCa), and most patients with PCa
metastases develop osteogenic bone metastasis, which manifests as disturbed bone …

Purpose The aim of this study was to evaluate potential differences in “Glu-NH-CO-NH-Lys”
radio-labeled with [68 Ga] gallium N, N-bis [2-hydroxy-5-(carboxyethyl) benzyl] …

The treatment of patients with metastatic prostate cancer (PCa) is considered to be a long‑
standing challenge. Conventional treatments for metastatic PCa, such as radical …

Purpose Bone fracture risk assessed ancillary to positron emission tomography with
computed tomography co-registration (PET/CT) could provide substantial clinical value to …